Search Results

Aurélien Rizk is a scientist and entrepreneur in drug discovery. Before focusing on the development of innovative mathematical modeling and simulation methods for drug discovery, Dr. Aurelien Rizk, a co-founder and CEO of Interax Biotech, shared about the company's development of a discovery Aurelien Rizk confirmed his attendance at the upcoming GPCR-Targeted Drug Discovery Summit in Boston.

Stay current in drug discovery with the University Vault. Quickly get up to speed on new GPCR targets and mechanisms, and gain a competitive edge with our extensive University Vault: The Ultimate On-Demand GPCR Learning Library Every talk inside the University Vault represents years of research, collaboration, and innovation that continue to shape the GPCR field. Anonymous This looks super useful for drug discovery!

GPCR Podcast Strategic Partners You never know where your GPCR takes you with Dr. He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening to this podcast episode

“Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs GPCR Courses 🔥 New Course Alert! “Development of GPCR Ligands as Therapeutic Drugs” with Dr. 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research Previous Next Recent Articles

GPCR Podcast Strategic Partners Robert Laprairie About Dr. Robert Laprairie Dr. Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening to this podcast episode

together to advance biology and therapeutics. 📚 Learn faster. 🤝 Connect deeper. 🔬 Drive discoveries helps shape the future of discovery. Explore 200+ expert talks that bring GPCR discoveries to life From structural biology to therapeutics every scientist needs to see pharmacology clearly, from core principles to the hidden variables of drug behaviors, and the strategies to drive successful drug discovery projects.

in life science innovation, delivering tools and technologies that bridge the gap between discovery unwavering focus on precision, Revvity empowers scientists to simplify complex workflows, accelerate discovery designing the next generation of therapeutics, Revvity isn’t just a provider—they’re your partner in discovery GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud Learn how pH Sense changes the game for drug discovery. Dr. GPCR Podcast Sep 26 3 min read Dr.

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and discovery. his mentors and significant discoveries related to allosteric receptors. discovery. Allosteric Modulation and Drug Discovery Yamina and Arthur delved into the complexities of protein-protein

Home → Flash News → Class B GPCR drugs are reshaping treatment for migraine, diabetes, and obesity- but This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #drgpcr Published on June 2, 2025 Category GPCR Weekly News Class B GPCR drugs are reshaping treatment This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock

Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially GPCR. In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Enjoying the Dr. GPCR Podcast?

GPCR Podcast Strategic Partners Scott Struthers R. he led contract research efforts at Biosym Technologies to develop and apply computational tools for drug discovery. co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused on the discovery GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Podcast Strategic Partners Dr. Prasenjit Saha About Dr. Specifically, I am interested in understanding dysregulated G-protein coupled receptor (GPCR) signaling Traditional drug discovery efforts have focused on agonists and antagonists that bind to the orthosteric ubiquitous class of plasma membrane receptors and serve as targets for more than one-third of all prescribed drugs GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Podcast Strategic Partners Dr. David E. Computational Receptor Biology at the University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical Data Science unit. one of the coordinators of recommendations to describe ligand bias towards signaling probes and safer drugs GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program Our first main research aspect is the identification of endogenous ligand of GPCRs. Our third main research aspect is working mechanism of GPCR. Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR (Cell 2021, 2023, Nature 2023b), bile acids or its derivatives by GPCRs (Nature 2020)."

Flash News → pharmacology at your fingertips terrys corner launches Published on July 4, 2025 Category GPCR Weekly News Stronger pharmacology drives smarter decisions in GPCR discovery. Elevate your drug discovery program with 45+ lessons yearly. GPCR Weekly: ♦️ Yamina’s Corner—GPCR consulting to de-risk and accelerate your pipeline ♦️ Celtarys’ validated TR-FRET assay for CB1/CB2 ♦️ Chemokine-GPCR selectivity decoded ♦️ PTH1R structures reveal

GPCR Podcast Strategic Partners Dr. Kari Johnson About this episode Dr. University before continuing her training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program signaling pathway of the ADGRA homolog Remoulade in Drosophila Beatriz Blanco Redondo The Adhesion GPCR The mammalian Remo homolog ADGRA2/Gpr124 cooperates with other GPCRs of the Frizzled family, and the Anaesthesiology and Intensive Care, Medical Faculty, Leipzig University, Leipzig, Germany 5 Institute for Drug Discovery, Faculty of Medicine, Leipzig University 6 School of Medicine, University of Global Health

#gpcr#drgpcr Published on May 26, 2025 Category GPCR Weekly News How do GPCRs sense pH changes? Antagonism Drug discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist GPCR Podcast 2 days ago How GPCR Spatial Signaling Sparked a Scientific Journey Michelle hadn’t mapped GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase GPCR News 5 days ago

Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization of Candidate pharmacologic techniques and knowledge required to create a GPCR Target Program aimed at the discovery of new Drugs. The required elements of a comprehensive and effective GPCR Discovery. Modules: October 3rd: GPCR Project Initiation and Design for Discovery of New Molecules.

unveiled the cryo-EM structure of TAS2R14, the most promiscuous bitter taste receptor, bound to the drug 🌟 This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound Published on December 5, 2024 Category GPCR Weekly News Ever wondered how we perceive bitterness? 🌟 This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound signaling. ➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/a-bitter-anti-inflammatory-drug-binds-at-two-distinct-sites-of-a-human-bitter-taste-gpcr

GPCR Podcast Strategic Partners Dr. Nicholas Holliday About Dr. and the immune system, and the molecular mechanisms underlying the signaling and regulation of their GPCRs Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR Podcast Strategic Partners Dr. Terry Kenakin About Dr. His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening to this podcast episode

This made me pursue my higher education in the field of adhesion GPCRs. Emmanouil Kyrloglou on the web Adhesion GPCR Consortium LinkedIn A single cell GPCR map of thermogenic , located within the GPCR autoproteolysis inducing (GAIN) domain. University" About Jesse Stillwell "Jesse Stillwell is a 3rd year graduate student with a research focus in drug His project is drug discovery focused, with particular interest in use of a novel epigenetic therapy

GPCR Podcast Strategic Partners Dr. Paul Insel About this episode In 1975, Dr. colleagues and Alfred Gillman , co-recipient of the 1994 Nobel Prize in Physiology or Medicine for their discovery , Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel drug GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR Podcast Strategic Partners Dr. Michel Bouvier About Dr. to our understanding of this major class of drug targets. energy transfer (BRET) resulted in the development of screening assays that are now widely used for drug discovery. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

AI is transforming GPCR modeling. scientists to go beyond explaining data — and start predicting the future of receptor function and drug discovery. News → ep 175 with jens carlsson clip 3 AI is changing how we think about structure, function, and discovery GPCR Podcast AI is changing how we think about structure, function, and discovery — but Jens Carlsson

GPCR Podcast Strategic Partners Dr. Khaled Abdelrahman About Dr. Khaled Abdelrahman Dr. He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Join Terry’s Corner AMA to master GPCR signaling, allosteric modulation, and kinetic strategy in drug discovery. In the discovery phase, one overlooked kinetic parameter or a misjudged model can set your team back It’s 45+ years of applied discovery experience from Terry Kenakin distilled into practical, modular lessons Don’t fall behind on what will shape the next decade of discovery.

GPCR Ecosystem. partner, you'll gain trusted access to an engaged audience of academic researchers, biotech teams, and drug discovery innovators—without having to fight for attention. GPCR? GPCR platform as a valued partner ✓ Share insights on product launches, scientific discoveries, or customer

Discover how enzyme inhibition can enhance drug discovery strategies. Home → Flash News → Weekly News October 16 Published on October 16, 2025 Category GPCR Weekly News Enzymes This week’s Weekly News is your practical guide to building enzyme inhibition into discovery—not as a #DrGPCR #GPCR Previous Next Recent Articles